Co-Diagnostics, Inc. (CODX) stock
CODXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.26−0.01 (-4.12%)
Close on Nov 13, 2026Market cap $1.62MP/E –Yield –
Co-Diagnostics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Co-Diagnostics's shares outstanding was 6M at Sep 30, 2026. For fiscal 2025 it was 1M, up 31.5% from the year before. The highest annual figure on record is 1M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1M | +31.5% |
| FY2024 | Dec 31, 2024 | 1M | +3.4% |
| FY2023 | Dec 31, 2023 | 1M | -6.8% |
| FY2022 | Dec 31, 2022 | 1M | +5.3% |
| FY2021 | Dec 31, 2021 | 1M | +6.8% |
| FY2020 | Dec 31, 2020 | 1M | +67.1% |
| FY2019 | Dec 31, 2019 | 1M | +34.2% |
| FY2018 | Dec 31, 2018 | 0M | +13.9% |
| FY2017 | Dec 31, 2017 | 0M | +10.9% |
| FY2016 | Dec 31, 2016 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 6M | +396.6% |
| Q2 FY2026 | Jun 30, 2026 | 4M | +290.5% |
| Q1 FY2026 | Mar 31, 2026 | 2M | +110.9% |
| Q4 FY2025 | Dec 31, 2025 | 2M | +83.0% |
| Q3 FY2025 | Sep 30, 2025 | 1M | +24.3% |
| Q2 FY2025 | Jun 30, 2025 | 1M | +9.9% |
| Q1 FY2025 | Mar 31, 2025 | 1M | +7.4% |
| Q4 FY2024 | Dec 31, 2024 | 1M | +4.8% |
| Q3 FY2024 | Sep 30, 2024 | 1M | +3.9% |
| Q2 FY2024 | Jun 30, 2024 | 1M | +3.6% |
| Q1 FY2024 | Mar 31, 2024 | 1M | +1.2% |
| Q4 FY2023 | Dec 31, 2023 | 1M | +9.5% |
| Q3 FY2023 | Sep 30, 2023 | 1M | -6.3% |
| Q2 FY2023 | Jun 30, 2023 | 1M | -10.4% |
| Q1 FY2023 | Mar 31, 2023 | 1M | -15.1% |
| Q4 FY2022 | Dec 31, 2022 | 1M | -10.3% |
| Q3 FY2022 | Sep 30, 2022 | 1M | +4.6% |
| Q2 FY2022 | Jun 30, 2022 | 1M | +9.2% |
| Q1 FY2022 | Mar 31, 2022 | 1M | +15.7% |
| Q4 FY2021 | Dec 31, 2021 | 1M | +3.0% |
| Q3 FY2021 | Sep 30, 2021 | 1M | +1.2% |
| Q2 FY2021 | Jun 30, 2021 | 1M | +2.0% |
| Q1 FY2021 | Mar 31, 2021 | 1M | +31.5% |
| Q4 FY2020 | Dec 31, 2020 | 1M | +75.5% |
| Q3 FY2020 | Sep 30, 2020 | 1M | +70.8% |
| Q2 FY2020 | Jun 30, 2020 | 1M | +71.3% |
| Q1 FY2020 | Mar 31, 2020 | 1M | +42.0% |
| Q4 FY2019 | Dec 31, 2019 | 1M | +28.5% |
| Q3 FY2019 | Sep 30, 2019 | 1M | +40.6% |
| Q2 FY2019 | Jun 30, 2019 | 1M | +37.9% |
| Q1 FY2019 | Mar 31, 2019 | 1M | +30.4% |
| Q4 FY2018 | Dec 31, 2018 | 0M | +5.0% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +4.9% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +24.8% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +24.7% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +24.5% |
| Q3 FY2017 | Sep 30, 2017 | 0M | – |
| Q2 FY2017 | Jun 30, 2017 | 0M | – |
| Q1 FY2017 | Mar 31, 2017 | 0M | – |
| Q4 FY2016 | Dec 31, 2016 | 0M | – |
See a number that looks wrong?